| Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes. | |
| | |
MedLine Citation:
|
PMID: 12239934 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND/AIMS: Hepatocellular carcinoma patients with paraneoplastic syndromes usually have a larger tumor volume and a higher serum alpha-fetoprotein. Whether the presence of paraneoplastic syndromes, such as hypercholesterolemia, hypoglycemia, hypercalcemia, and erythrocytosis in hepatocellular carcinoma patients is a significant prognostic factor in patients' survival is of clinical interest. METHODOLOGY: We evaluated the occurrence of paraneoplastic syndromes in 903 hepatocellular carcinoma patients; 179 (20%) patients developed paraneoplastic syndromes either upon diagnosis or during follow-up, 179 age-sex-tumor volume-matched hepatocellular carcinoma patients without paraneoplastic syndromes were selected as controls. Serum liver biochemistry, alpha-fetoprotein, clinical Child-Pugh's score, tumor image studies, histological features, accessibility to treatment, and survival were recorded and compared between patients with and without paraneoplastic syndromes. Prognostic factors in patients' survival were analyzed. The clinical course and survival of hepatocellular carcinoma patients with different paraneoplastic syndromes were also compared. RESULTS: Multivariate Cox regression analysis revealed Child-Pugh's grade C, ineligibility for active treatment, serum alpha-fetoprotein > 10,000 ng/mL, main portal vein tumor thrombosis, and the presence of paraneoplastic syndromes were all independent unfavorable prognostic factors for survival. The median survival from the occurrence of paraneoplastic manifestation to death was only 36 days. Patients with different paraneoplastic syndromes had similar clinical characteristics in Child-Pugh's score, serum alpha-fetoprotein level, tumor volume, prevalence of main portal vein tumor thrombosis, and accessibility for active treatment upon diagnosis. However, erythrocytosis and hypercholesterolemia usually developed earlier in the clinical course, whilst hypoglycemia and hypercalcemia were usually terminal events. Hepatocellular carcinoma patients with erythrocytosis tended to have a longer survival than patients with other paraneoplastic syndromes. CONCLUSIONS: The presence of paraneoplastic syndromes in hepatocellular carcinoma patients is an unfavorable prognostic factor, excluding the occurrence of erythrocytosis. |
| | |
Authors:
|
Jiing-Chyuan Luo; Shinn-Jang Hwang; Jaw-Ching Wu; Chiung-Ru Lai; Chung-Pin Li; Full-Young Chang; Jen-Huei Chiang; Wing-Yiu Lui; Chen-Wei Chu; Shou-Dong Lee |
Related Documents
:
|
2436674 - 5-hiaa and hva in csf in patients with idiopathic pain disorders. 8444474 - Routine diagnosis of digeorge syndrome by fluorescent in situ hybridization. 20678334 - Pandemic (h1n1) 2009 virus and down syndrome patients. 3262264 - Neurotological findings in bell's palsy and hunt's syndrome. 15365454 - Clinical features of nsd1-positive sotos syndrome. 22483344 - Beckwith-wiedemann syndrome, delayed abdominal wall closure, and neonatal intussuscepti... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Hepato-gastroenterology Volume: 49 ISSN: 0172-6390 ISO Abbreviation: Hepatogastroenterology Publication Date: 2002 Sep-Oct |
Date Detail:
|
Created Date: 2002-09-20 Completed Date: 2003-01-23 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8007849 Medline TA: Hepatogastroenterology Country: Greece |
Other Details:
|
Languages: eng Pagination: 1315-9 Citation Subset: IM |
Affiliation:
|
Division of Gastroenterology, Department of Medicine, Veterans General Hospital-Taipei, National Yang-Ming University School of Medicine, Taipei, Taiwan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carcinoma, Hepatocellular
/
epidemiology*,
mortality Comorbidity Female Humans Liver Neoplasms / epidemiology*, mortality Male Paraneoplastic Syndromes / epidemiology* Polycythemia / epidemiology Prognosis Regression Analysis |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Malignant gastrointestinal stromal tumor of the jejunum with liver metastasis.
Next Document: Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-alpha) in Slovenia.